ZUMA-7 trial shows the value of axicabtagene ciloleucel for early relapsed B-cell lymphoma. Nierengarten MB. Cancer 2023;129:2926.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nierengarten MB. ZUMA-7 trial shows the value of axicabtagene ciloleucel for early relapsed B-cell lymphoma. Cancer 2023;129:2926.
PMID: 37656154